Author Archives: Decia Wong

Successful First-in-Human Clinical Study of Kardium’s Next Generation Globe® Pulsed Field System

11/08/2022

VANCOUVER, British Columbia – Kardium Inc. announces the successful first-in-human study of its next generation Globe® Pulsed Field System to treat atrial fibrillation (AF) using pulsed field ablation (PFA) therapy. Working with Dr. Vivek Reddy* from Mount Sinai Hospital (New York, USA), and Prof. Petr Neužil and Dr. Jan Petrů from Na Homolce Hospital (Prague, Czech […]

Read More

Kardium’s Globe® System Begins Clinical Trial at St. Paul’s Hospital

04/12/2022

VANCOUVER, British Columbia – Kardium Inc. announces a successful first-in-BC investigational* clinical procedure using the Globe® Mapping and Ablation System. Dr. Marc Deyell of St. Paul’s Hospital leads the study using the Globe System to navigate inside the heart and diagnose where the rhythm disturbances occur. Once identified, the same device can then deliver immediate treatment to restore […]

Read More

First-in-Human Trial of Pulsed Field Ablation with Kardium’s Globe® PF System

12/15/2021

VANCOUVER, British Columbia – Kardium Inc. announces the completion of successful first-in-human (FIH) procedures with the Globe Pulsed Field System. Dr. Vivek Reddy of Mount Sinai Hospital in New York, USA and Prof. Petr Neužil of Na Homolce Hospital in Prague, Czech Republic, performed the procedures in Prague last week. Dr. Jacob Koruth of Mount Sinai Hospital […]

Read More

Kardium announces $115M in new financing for innovative atrial fibrillation treatment

01/25/2021

VANCOUVER, British Columbia – Kardium Inc., developer of the Globe® Mapping and Ablation System for the treatment of atrial fibrillation, has raised US $115 million in a new financing round. The round is led by Fidelity Management & Research Company LLC., together with follow-on participation by funds and accounts advised by T. Rowe Price Associates, Inc. […]

Read More

Kardium performs first cases with the Globe® Positioning System

11/11/2020

VANCOUVER, British Columbia – Kardium is pleased to announce the first clinical use of the Globe Positioning System (GPS™) – the new 3D mapping and navigation feature of its flagship product, the Globe® Mapping and Ablation System. The Globe System is the most complete solution for the treatment of atrial fibrillation (AF) – the world’s […]

Read More

Kardium Marks First Commercial Procedures of Globe® Mapping and Ablation System

09/08/2020

VANCOUVER, British Columbia – Kardium Inc. announced the first commercial procedures with the Globe Mapping and Ablation System. The Globe System is the most complete solution for the treatment of atrial fibrillation (AF) – the world’s most common heart rhythm disorder, affecting more than 37 million people. The first patients were treated in Europe. During […]

Read More